Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited
Filing
474
ORDER re 473 Exhibit filed by Novo Nordisk A/S, Novo Nordisk, Incorporated. Signed by District Judge Avern Cohn. (JOwe)
Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited
Doc. 474
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION NOVO NORDISK A/S, et al., Plaintiffs, -vsCARACO PHARMACEUTICAL LABORATORIES, LTD., et al., Defendants. ________________________________/ ORDER Novo Nordisk's objections to DX 394 and DX 477A (Doc. 473) are OVERRULED for the reasons stated on the record on July 20, 2010. Particularly, DX 394 is a demonstrative exhibit displaying in graphic form the results of the testing described in DX 201, DX 61 (which is a duplicate of PX 44) and DX 246, publications which were identified in the testimony. Particularly, DX 477A is a graphic display of diabetic drugs identified in the testimony. SO ORDERED. Case No. 05-40188 Hon: AVERN COHN
Dated: July 22, 2010
S/Avern Cohn AVERN COHN UNITED STATES DISTRICT JUDGE
I hereby certify that a copy of the foregoing document was mailed to the attorneys of record on this date, July 22, 2010, by electronic and/or ordinary mail. S/Julie Owens Case Manager, (313) 234-5160
Dockets.Justia.com
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?